Latest News Feed
Board-certified physicians use the ZetrOZ Systems sustained acoustic medicine device for injury healing and pain relief without invasive surgery or potentially addictive and dangerous medications.
First-year graduate students at Merrimack College taking Therapeutic Modalities will learn about the effects and benefits of long-duration, sustained acoustic medicine (sam®) on soft-tissue healing.
ZetrOZ's sam®️ technology promotes soft tissue healing, helping patients return to work sooner and preventing more severe injuries; the only FDA-cleared home-use multi-hour ultrasound stimulator.
ZetrOZ Systems will showcase its sustained acoustic medicine (sam®) technology, a non-invasive, non-systemic treatment option for soft-tissue injuries experienced in the workplace and beyond. The companies' partnerships with self-insured and insurance providers has expanded access to millions of lives in America.
The wireless, long-duration, continuous, ultrasound, patch-based stimulator delivers 33 times more treatment than pulsed ultrasound devices and is authorized by the FDA for prescription home use in the United States of America.
The wearable sustained acoustic medicine (sam®) treatment has been effectively utilized by sports medicine doctors, athletes and beyond to help rapidly treat tendon, ligament and other soft-tissue injuries.
A sam® regimen prioritizes healing beyond the pain to emphasize the importance of returning patients fully back to health to minimize the risk of chronic, recurring injuries.
New clinical research sheds light on the use of sam®, a medical ultrasound device for prescription home use, for pain mitigation in soft tissue injuries.
At a recent conference of professional hockey trainers, ZetrOZ Systems, a leading innovator and inventor of sustained acoustic medicine (sam®) for soft tissue injury healing, presented results of studies indicating the medical device is highly effective at treating the types of injuries hockey players frequently experience.
sam® by Zetroz Systems utilizes high-frequency, low-intensity continuous ultrasound to facilitate the healing of injured musculoskeletal tissue in the home of the patient.
Effective management of a company's intellectual property can create significant advantages, crucial in today's competitive health technology marketplace.
Creator of sustained acoustic medicine soft tissue healing device reports that even FDA-cleared devices backed by body of research and millions of successful treatments still face hurdles.
ZetrOZ Systems' musculoskeletal ultrasound device facilitates return to regular activities
Sustained Acoustic Medicine Inventors ZetrOZ Systems Outlines How Patients and Providers Can Work Together in Accessing Healthcare Benefits
Innovative medical technologies like the sam® device promote soft tissue healing
Sustained Acoustic Medicine developer avoids supply chain tangles to supply healthcare providers with needed medical intervention.
New research demonstrates how sustained acoustic medicine (SAM) accelerates healing and recovery from soft tissue injury common in college and professional sports
Innovative, wearable, FDA-cleared long-duration ultrasound device proven effective in rehabilitation and pain management, medical journal review reports.
Dr. George Lewis, inventor of sam® soft tissue healing pain relief ultrasound device, to review 2022 clinical research on technology and patient outcomes
Cutting-edge sustained acoustic medicine soft tissue healing treatment developed in partnership with federal research support will now help federal workers recover from injury and improve surgery outcomes.
Wearable ultrasound sam® device heals soft tissue injuries faster, reduces need for surgery and pain medications.
Groundbreaking ultrasound therapy company helps the Whale and other sports teams recover, manage pain and stay in the game
Sustained acoustic medicine (sam®) device for soft tissue injuries is available for patients and healthcare providers to amplify the body's natural ability to heal by increasing local circulation
Wearable ultrasound technology from ZetrOZ Systems meets patients' need for for drug-free, non-invasive treatment extending healing to the home
Wearable ultrasound therapy for home use assists in healing and reduces reliance on narcotic pain medications, which only mask pain
The pain management ultrasound device helps heal injuries and return employees back to work without surgery or narcotics.
ZetrOZ's Sustained Acoustic Medicine (samⓇ) backed by 15 years of research, 30 clinical studies, 300,000 patients
The wearable sustained acoustic medicine (sam®) device has been leveraged by athletes to help treat injuries sustained during competition
The FDA-cleared home-use ultrasound device will be featured at the world's largest gathering of orthopaedic surgeons
SAMⓇ, the only FDA-cleared, wearable home ultrasound device will display its healing functions at the world's largest event for chiropractic medicine.
As industry ramps up to pre-pandemic levels, the pain management ultrasound device helps employers and workers minimize effects of workplace injury
ZetrOZ Systems' long-duration ultrasound device provides new options for orthopedic surgeons
American-made products mean more transparency and higher standards, resulting in a better overall product and customer experience.
Company achieves first and only FDA-approved, wearable device for multi-hour continuous ultrasound therapy for home-use.
Dr. George Lewis of ZetrOZ Systems to present results of large clinical trial at Special Operations Medical Association's annual Scientific Assembly
ZetrOZ Systems partners with Dr. Rod Walters, nationally recognized sports medicine clinical educator, for an upcoming course on soft-tissue regeneration and rapid response care.
Retired Army Ranger tells how ZetrOZ Systems' Sustained Acoustic Medicine (SAM) device has helped him rehab from injuries
Structures in the healthcare system often stifle innovation and breakthrough treatments.
ZetrOZ partners with many women's sports organizations to promote Sustained Acoustic Medicine (SAM) as a treatment for various forms of chronic and acute pain.
Dr. George Lewis outlines benefits and effectiveness of novel technology for non-invasive, non-opioid pain relief
The bill aims to expand provider access to FDA-approved, non-opioid pain management approaches. Sustained Acoustic Medicine, developed by ZetrOZ Systems, is among those approaches.
New study finds vast majority of athletic trainers confident in value of sustained acoustic medicine technology
ZetrOZ and the NIA aim to develop new pain-relieving innovations and help make them available to the public faster.
Review finds ZetrOZ technology also lowers treatment costs significantly improving care for the aging patient population
Spring training means Baseball season is almost underway after an early ending last season due to the pandemic.
sam® wearable ultrasound device has helped career law enforcement officers injured in the line of duty reduce chronic pain and get their lives back.
ZetrOZ is expanding the utilization of Sustained Acoustic Medicine to help 100 million people with soft-tissue injuries and chronic pain
Sustained Acoustic Medicine (SAM) is now part of the majority of university curriculum for Athletic Training, Physical Therapy, and Occupational Therapy students, as well as pre-med students learning about mechanobiology.
